CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.595051
-0.0217 (-3.53%)
Sep 9, 2026, 11:10 AM EDT - Market open
CDT Equity Employees
CDT Equity had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$9,286,750
Market Cap
8.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 38 |
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| Soligenix | 14 |
| Ensysce Biosciences | 10 |
| CNS Pharmaceuticals | 8 |
| Traws Pharma | 7 |
| Alzamend Neuro | 6 |
CDT News
- 17 hours ago - CDT Equity files to sell 16.83M shares of common stock for holders - TheFly
- 7 days ago - CDT Provides Capital Update and Confirms No Nasdaq Deficiencies - GlobeNewsWire
- 8 days ago - CDT Equity appoints James Bligh as CEO - TheFly
- 8 days ago - CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth - GlobeNewsWire
- 12 days ago - CDT Equity validates enhanced solid-form properties in IP portfolio - TheFly
- 12 days ago - CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio - GlobeNewsWire
- 15 days ago - CDT Equity announces investment in Pep’d Inc. - TheFly
- 15 days ago - CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market - GlobeNewsWire